1st Bank & Trust reduced its stake in Edwards Lifesciences by 44.9%, now holding 12,091 shares.
1st Bank & Trust cut its stake in Edwards Lifesciences Co. by 44.9%, now holding 12,091 shares valued at $798,000. Other institutional investors also adjusted their holdings. The stock has a "Hold" rating with a target price of $75.67. Recently, insiders sold 16,250 shares worth over $1.1 million, holding only 1.29% of shares. The stock opened at $69.38, with a twelve-month range of $58.93 to $96.12. Analysts anticipate an EPS of 2.71 for the fiscal year.
October 26, 2024
10 Articles